These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 27328763

  • 1. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S.
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 3. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 4. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X, Tian F, Wu B, Xu T.
    Cochrane Database Syst Rev; 2022 Mar 29; 3(3):CD010893. PubMed ID: 35349164
    [Abstract] [Full Text] [Related]

  • 5. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y.
    Adv Rheumatol; 2020 Jan 30; 60(1):12. PubMed ID: 32000860
    [Abstract] [Full Text] [Related]

  • 6. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y, Gezer HH, Duruöz MT.
    Rheumatol Int; 2022 Jan 30; 42(1):81-86. PubMed ID: 34550430
    [Abstract] [Full Text] [Related]

  • 7. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B, Xu T, Li Y, Yin X.
    Cochrane Database Syst Rev; 2018 Oct 19; 10(10):CD010893. PubMed ID: 30338514
    [Abstract] [Full Text] [Related]

  • 8. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T, Aydın F, Nilüfer Tekgöz P, Sezer M, Uncu N, Çelikel Acar B.
    Int J Rheum Dis; 2020 Jul 19; 23(7):977-981. PubMed ID: 32558310
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R, Ozturk MA, Goker B, Tufan A, Haznedaroglu S.
    J Clin Rheumatol; 2020 Jan 19; 26(1):7-13. PubMed ID: 30048391
    [Abstract] [Full Text] [Related]

  • 10. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
    Ozen S, Bilginer Y, Aktay Ayaz N, Calguneri M.
    J Rheumatol; 2011 Mar 19; 38(3):516-8. PubMed ID: 21159830
    [Abstract] [Full Text] [Related]

  • 11. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A.
    Best Pract Res Clin Rheumatol; 2016 Apr 19; 30(2):296-303. PubMed ID: 27886801
    [Abstract] [Full Text] [Related]

  • 12. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
    Laskari K, Boura P, Dalekos GN, Garyfallos A, Karokis D, Pikazis D, Settas L, Skarantavos G, Tsitsami E, Sfikakis PP.
    J Rheumatol; 2017 Jan 19; 44(1):102-109. PubMed ID: 28042127
    [Abstract] [Full Text] [Related]

  • 13. Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.
    Sag E, Akal F, Atalay E, Akca UK, Demir S, Demirel D, Batu ED, Bilginer Y, Ozen S.
    Rheumatology (Oxford); 2020 Nov 01; 59(11):3324-3329. PubMed ID: 32306038
    [Abstract] [Full Text] [Related]

  • 14. Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients.
    Varan O, Kucuk H, Babaoglu H, Atas N, Salman RB, Satis H, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Clin Rheumatol; 2019 Apr 01; 38(4):1125-1130. PubMed ID: 30535829
    [Abstract] [Full Text] [Related]

  • 15. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G, Kose R, Senturk T.
    Sao Paulo Med J; 2019 May 08; 137(1):39-44. PubMed ID: 31116269
    [Abstract] [Full Text] [Related]

  • 16. Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment.
    Alpa M, Roccatello D.
    Drug Des Devel Ther; 2015 May 08; 9():1983-7. PubMed ID: 25945034
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.
    Erkilet HK, Gezgin Yildirim D, Esmeray P, Söylemezoğlu O.
    Pediatr Int; 2023 May 08; 65(1):e15588. PubMed ID: 37658625
    [Abstract] [Full Text] [Related]

  • 18. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F.
    Clin Rheumatol; 2016 Feb 08; 35(2):441-6. PubMed ID: 25213327
    [Abstract] [Full Text] [Related]

  • 19. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.
    Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, Cınar M, Yilmaz S, Onat AM, Kisacik B, Erden A, Balkarli A, Kucuksahin O, Oner SY, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarlıoglu M, Dogru A, Yildirim G, Oner FA, Tezcan ME, Pamuk ON, Onen F.
    Arthritis Care Res (Hoboken); 2018 Jul 08; 70(7):1090-1094. PubMed ID: 28992387
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis.
    Kilic B, Guler Y, Azman FN, Bostanci E, Ugurlu S.
    Rheumatology (Oxford); 2024 Apr 02; 63(4):925-935. PubMed ID: 37769252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.